These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1656248)

  • 21. Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders.
    Purtilo DT
    Biomed Pharmacother; 1985; 39(2):52-8. PubMed ID: 2990590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases.
    Andiman W; Gradoville L; Heston L; Neydorff R; Savage ME; Kitchingman G; Shedd D; Miller G
    J Infect Dis; 1983 Dec; 148(6):967-77. PubMed ID: 6317774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects.
    Schuster V; Kreth HW
    Eur J Pediatr; 1992 Oct; 151(10):718-25. PubMed ID: 1330572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epstein-Barr virus infections. New pathogenic and clinical aspects].
    Wilmes E; Wolf H
    Laryngorhinootologie; 1989 Jan; 68(1):36-43. PubMed ID: 2536874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Epstein-Barr virus in the etiology of Burkitt's lymphoma.
    Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H; Tatsumi E
    IARC Sci Publ; 1985; (60):231-47. PubMed ID: 2998991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New oncologic associations for the Epstein-Barr virus.
    Gartner JG; Seemayer TA
    Am J Surg Pathol; 1982 Jul; 6(5):471-3. PubMed ID: 6289684
    [No Abstract]   [Full Text] [Related]  

  • 29. Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro.
    Sugden B
    Rev Infect Dis; 1982; 4(5):1048-61. PubMed ID: 6293034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families.
    Schuster V; Dohrmann E; Kreth HW
    Cancer Detect Prev; 1991; 15(1):65-7. PubMed ID: 1646073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
    Chappuis BB; Müller-Hermelink HK
    Environ Health Perspect; 1990 Aug; 88():237-41. PubMed ID: 2176977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders.
    Yang X; Nishida N; Zhao X; Kanegane H
    Iran J Allergy Asthma Immunol; 2015 Oct; 14(5):462-71. PubMed ID: 26742434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squamous-cell carcinoma, Kaposi's sarcoma and Burkitt's lymphoma are consequences of impaired immune surveillance of ubiquitous viruses in acquired immune deficiency syndrome, allograft recipients and tropical African patients.
    Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H
    IARC Sci Publ; 1984; (63):749-70. PubMed ID: 6100288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus and its antigens.
    Raab-Traub N; Pagano JS
    Immunol Ser; 1989; 43():477-98. PubMed ID: 2562309
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
    Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
    Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epstein-Barr virus infection: immunology and immunopathology].
    Geelen SP; Kuis W; Roord JJ; Stoop JW; Kapsenberg JG
    Ned Tijdschr Geneeskd; 1986 Jan; 130(2):63-7. PubMed ID: 3005887
    [No Abstract]   [Full Text] [Related]  

  • 38. [The spectrum of infections caused by the Epstein-Barr virus].
    Glauser MP
    Schweiz Med Wochenschr; 1983 Jul; 113(26):934-8. PubMed ID: 6310735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus-associated lymphoproliferative disorders.
    Ambinder RF
    Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.
    Purtilo DT; DeFlorio D; Hutt LM; Bhawan J; Yang JP; Otto R; Edwards W
    N Engl J Med; 1977 Nov; 297(20):1077-80. PubMed ID: 198660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.